abstract |
The present invention relates to novel compounds of formula (I) having HCV protease inhibitory activity and methods of preparing the compounds. In another aspect, the invention relates to pharmaceutical compositions comprising the compounds and methods of using the same to treat disorders associated with HCV proteases. |